Ophthalmic Drugs Market by Drug Class (Anti-inflammatory Drugs [Non Steroidal Anti-Inflammatory Drugs and Steroids], Anti-Infective Drugs [Anti-Fungal Drugs, Anti-Bacterial Drugs, Anti-Viral Drugs, and Others], Anti-Glaucoma Drugs [Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, and Others], Anti-Allergic Drugs, and Others), by Type (Prescription Drugs and Over-the-Counter Drugs), by Disease Indication (Dry Eye, Allergies, Glaucoma, Retinal Disorders, Inflammation/ Infection, Uveitis, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global ophthalmic drugs market expected to generate revenue of around USD 34.52 billion by end of 2024, growing at a CAGR of around 4.70% between 2018 and 2024. Ophthalmic drugs are used in the treatment of cataract, retinopathy, glaucoma, diabetic, and other disorders.

20-Sep-2018 | Number of pages: 110 | Report Code: ZMR-3372 | Report Format : | Status : Published

Analysis

Ophthalmology deals with the diagnosis, treatment, and prevention of diseases which are associated with the visual system. Most of the eye-related disorders occur over a long period of time and at initial phase are usually asymptomatic or cause a slight decrease in the vision. However, over time this becomes quite distinct. Ophthalmologic disorders cannot be cured completely; however, the treatment aims at managing the disease indication to reduce the severity or slow its progression. Ophthalmologists provide around 85% of their procedure-based services to the seniors. Cataract surgery is the most frequent surgical procedure which is performed in many countries. 

Factors driving the ophthalmic drugs market are the increasing focus of the market players in the emerging economies to tap the unmet medical needs, increasing number of co-development agreements among leading players to make novel biological drugs which have less treatment duration, high proportion of visually challenged population, and generic manufacturers trying to strengthen their distribution networks for cost-effective drugs in developing regions. Moreover, rising prevalence of intraocular eye disorders, age-related macular degeneration, glaucoma, diabetic retinopathy, etc., in the elderly population is also boosting the global ophthalmic drugs market growth. Several organizations globally are increasing allocations on investments in research and development to come up with more effective novel biological agents. However, some of the factors like longer approval timelines required for ophthalmic drugs and loss of patent protection for drugs can hinder the market growth for ophthalmic drugs.

Global Ophthalmic Drugs Market

The ophthalmic drugs market is segmented based on drug type, disease indication, type, and distribution channel. Based on drug class, the market is segmented into anti-inflammatory drugs, antiglaucoma drugs, anti-allergic drugs, anti-infective drugs, and others. The anti-inflammatory drugs are further segmented into nonsteroidal anti-inflammatory drugs and steroids. The anti-infective drugs are further divided into anti-fungal drugs, anti-viral drugs, antibacterial drugs, and others. The anti-glaucoma drugs are segmented into combined medication, alpha agonist, prostaglandin analogs, beta blockers, and others. Based on type, the market is segmented into hospital prescription drugs and over-the-counter drugs. The ophthalmic drugs market is divided on the basis of disease indication into dry eye, allergies, glaucoma, retinal disorders, inflammation/infection, uveitis, and others. Based on the distribution channel, the market is segmented into online sales, retail pharmacies, hospital pharmacies, and others.

North America holds the largest share in the ophthalmic drugs market. This growth is mainly attributed to the huge number of R&D activities in the field of drug discovery. The region also has a large presence of a number of multinational biotech and pharma companies which carry out a large number of clinical trials and also have well developed and advanced healthcare infrastructure. Due to the high healthcare investment and rising government funding, Europe also holds a maximum share of the market followed by North America. Numerous market players are actively involved in the expansion of existing ophthalmic drugs to meet the rising demands for treatment of eye diseases. Besides, approval of new drugs for treating eye disorders by the European Union is also propelling the market for ophthalmic drugs in Europe. Asia Pacific region is also witnessing significant growth rate owing to the unmet health care needs and government funding towards research activities. Numerous ophthalmology companies are investing in the relatively untapped markets in the region to grow their revenue. India, China, and Malaysia are the most attractive markets in Asia Pacific owing to its rising healthcare spendings, substantial consumer base, and patient inclination to avail improved healthcare facilities.

Some of the leading players in ophthalmic drugs market include Allergan Plc, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Novartis AG, Bayer AG, F.Hoffmann-La Roche Ltd., Santen Pharmaceutical Co. Ltd., Kyowa Hakka Kirin Co. Ltd., Valent Pharmaceuticals International, Inc., Johnson and Johnson Vision Care, Inc., and Shire Plc. In March 2017, Allergan selected Aptar Pharma’s ophthalmic squeeze dispenser system for its new dry eye product, Restasis Multidose to treat the patients with the chronic dry eye. 


Related Reports

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Plantar Fasciitis Treatment Market: by Type (Medication Therapy [Oral, and Parenteral], Orthotics, Shockwave Therapy [Extracorporeal Shock Wave Therapy, and Intracorporeal Pneumatic Shockwave Therapy], Surgery, and Others), and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5116 | Report Format:

According to the report, global demand for plantar fasciitis treatment market was valued at USD 603.3 million in 2018, and is expected to generate revenue of USD 2,469.1 million by end of 2025, growing at a CAGR of 22.3% between 2019 and 2025 The report covers forecast and analysis for the globa...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.